Designing a polyvalent inhibitor of anthrax toxin

Nature Biotechnology

Volumn 19, Issue 10, 2001, Pages 958-961

  Mourez, Michael ^a   Kane, Ravi S ^b   Mogridge, Jeremy ^a   Metallo, Steve ^b   Deschatelets, Pascal ^b   Sellman, Bret R ^a   Whitesides, George M ^b   Collier, R John ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; ENZYMES; PROTEINS;

BIOLOGICAL ACTIVITY;

BIOTECHNOLOGY;

ANTHRAX TOXIN; ANTITOXIN; PEPTIDE; PEPTIDE LIBRARY; POLYVALENT INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CELL SURFACE; CONTROLLED STUDY; COVALENT BOND; DRUG DESIGN; DRUG SCREENING; INTOXICATION; LIGAND BINDING; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT;

ACRYLIC RESINS; ADENYLATE CYCLASE; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; CARRIER PROTEINS; CHO CELLS; CRICETINAE; DRUG DESIGN; ENZYME-LINKED IMMUNOSORBENT ASSAY; PEPTIDE LIBRARY; PEPTIDES; PROTEIN BINDING; RATS; RATS, INBRED F344;

EID: 0034784582     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt1001-958     Document Type: Article

References (24)

1. Anthrax
2. Anthrax toxins
3. Crystal structure of the anthrax toxin protective antigen
4. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor
5. Phage-displayed peptide libraries
6. Residues 1-254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides
7. Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors
8. Polyacrylamides bearing pendant-sialoside groups strongly inhibit agglutination of erythrocytes by influenza virus
9. A trivalent system from vancomycin. D-ala-D-Ala with higher affinity than avidin-biotin
10. Synthetic polymeric sialoside inhibitors of influenza virus receptor-binding activity
11. Synthetic ligands point to cell surface strategies
12. Spanning binding sites on allosteric proteins with polymer-linked ligand dimers
13. Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands
14. Protective antigen-binding domain of anthrax lethal factor mediates translocation of a heterologous protein fused to its amino- or carboxy-terminus
15. Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin
16. Anthrax protective antigen forms oligomers during intoxication of mammalian cells
17. Tumor targeting with a selective gelatinase inhibitor
18. Small peptides as potent mimetics of the protein hormone erythropoietin
19. Anthrax protective antigen: Prepore-to-pore conversion
20. Identification of residues lining the anthrax protective antigen channel
21. Effect of anthrax toxin's lethal factor on ion channels formed by the protective antigen
22. Effective inhibitors of hemagglutination by influenza virus synthesized from polymers having active ester groups. Insight into mechanism of inhibition
23. How to measure and predict the molar absorption coefficient of a protein
24. Characterization of membrane translocation by anthrax protective antigen